|
|
Binance |
|
|
Coinbase |
|
|
KUCOIN |
|
|
AscendEX (Formally BitMax) |
By Trader Edge at 2026-09-20 14:01
Sentiment: Negative
TLDR SYRE dropped 14% in after-hours trading Tuesday after scrapping SPY072 as a standalone RA treatment Both doses of SPY072 beat placebo in the SKYWAY Phase 2 trial but failed to meet Spyre’s own internal performance threshold The trial enrolled 143 participants; adverse events were comparable to or lower than placebo Spyre expects Phase 2 [...] The post Spyre Therapeutics (SYRE) Stock Drops 14% After Phase 2 RA Trial Disappoints appeared first on CoinCentral. Continue reading...
Categories: Stocks
Tags: #Stocks
Source Coin Central